| 000 | 00801 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250512194947.0 | ||
| 264 | 0 | _c19800726 | |
| 008 | 198007s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(80)91428-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBateman, D N | |
| 245 | 0 | 0 |
_aMetoclopramide in renal failure. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMay 1980 |
||
| 300 |
_a982 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xurine |
| 650 | 0 | 4 |
_aMetoclopramide _xmetabolism |
| 700 | 1 | _aGokal, R | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8175 _gp. 982 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(80)91428-2 _zAvailable from publisher's website |
| 999 |
_c6103414 _d6103414 |
||